Gaingels

Gaingels is a venture investment syndicate founded in 2014 and based in Burlington, Vermont, dedicated to supporting the LGBT+ community and its allies. The organization invests in companies led by LGBT+ founders and executives at all stages of development, as well as in established firms committed to enhancing their diversity and inclusivity. With a global portfolio comprising over 130 companies and $70 million in investment capital deployed, Gaingels plays a vital role in fostering an inclusive business environment. Additionally, the Gaingels network actively assists its portfolio companies in identifying and recruiting diverse talent for their leadership teams, while cultivating a vibrant community of industry leaders, investors, and entrepreneurs committed to driving positive social change through business initiatives.

Marc Baum

Investor

Jesse Curran

Principal

Ashley Flucas

Venture Partner

Rachael Foo

Investor

Todd Havill

Research Operations and Principal, Investment

Surya Jayaweera

Angel Investor

Jennifer Jeronimo

CEO and General Partner

Chris Leiter

Venture Partner and Investor

Jake Prigoff MD

General Partner

Alexandra Tanner

Investor

Past deals in Healthcare

Cofertility

Series A in 2025
Cofertility is a human-centered fertility ecosystem that provides egg donation and egg-freezing services for fertility care and third-party reproduction.

Ignota Labs

Seed Round in 2025
Ignota Labs is a medical technology company focused on enhancing the drug discovery process by utilizing advanced artificial intelligence methods, including deep learning and machine learning. The company's platform aims to optimize the identification of toxic compounds, which can lead to costly delays and safety errors in bringing new medications to market. By predicting toxic endpoints early in the development process, Ignota Labs not only improves drug safety but also promotes sustainability within the pharmaceutical industry by minimizing environmental harm and waste associated with harmful compounds.

Afynia Laboratories

Seed Round in 2025
Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.

Arda Therapeutics

Series A in 2024
Arda Therapeutics is a biotechnology company founded in 2021 in the San Francisco Bay Area that focuses on addressing chronic diseases and aging by targeting and eliminating pathogenic cells responsible for these conditions. The company utilizes single-cell data to identify specific pathogenic cells and their markers, allowing for the development of precise therapies that exclusively eliminate these harmful cells. This targeted approach aims to eradicate the entire pathological network while preserving healthy cells, thereby enabling effective treatment without adverse effects on the patient's overall cellular health.

Superluminal Medicines

Series A in 2024
Superluminal Medicines is a generative biological and chemical company accelerating new possibilities in drug discovery and development. Its platform quickly creates candidate-ready compounds using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure. They leverage cutting-edge computational and machine-learning techniques to accelerate identifying and optimizing novel drug candidates. Their approach combines high-throughput experimental data with advanced algorithms to uncover therapeutic compounds faster and more efficiently than traditional methods.

Afynia Laboratories

Seed Round in 2024
Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.

OverT Bio

Seed Round in 2024
OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the barriers posed by tumors. By enhancing the effectiveness and durability of immunotherapies, OverT Bio aims to advance the healthcare field's ability to identify and ultimately cure cancer.

Testmate Health

Seed Round in 2024
Testmate Health is a medtech startup and an award-winning spin-off of the University of Geneva, focused on developing innovative healthcare solutions. The company has created a smartphone-compatible test kit that can diagnose diseases with identifiable DNA or RNA sequences, providing results directly at home in just minutes. Its first product is a rapid urine self-test for the four most common sexually transmitted diseases, addressing the urgent need for timely diagnosis, as one million new STDs are diagnosed daily. Traditional testing often requires lab work and can take up to seven days for results. Testmate Health's all-in-one kit is designed for ease of use, allowing users to obtain immediate results that can be scanned by a smartphone for quick access to treatment if necessary. The company is also working on additional test kits for other diseases, aiming to empower individuals to manage their health conveniently from home.

Limbic

Series A in 2024
Limbic is a London-based company that specializes in mental healthcare technology. Founded in 2017, it develops a software development kit (SDK) that leverages machine learning to analyze heart rate data collected from wearable devices like the Apple Watch, allowing for the assessment of users' emotional states. Limbic also offers psychological therapies for adults, focusing on improving mental health through innovative solutions. Its platform supports healthcare professionals by providing tools for stress detection and facilitating clinical assessments, thereby enhancing the efficacy of psychological therapy. By combining AI technology with wearable devices, Limbic aims to address the growing challenges in mental health care and improve patient outcomes.

Ezra AI

Series B in 2024
Ezra AI, Inc. specializes in developing artificial intelligence technology-based investigational devices aimed at early cancer detection. The company utilizes full-body MRI scans enhanced by AI to innovate cancer screening methods. Its initial product, an AI software designed to assist radiologists in interpreting prostate MRI images, has received FDA clearance as a medical device. Founded in 2017, Ezra AI is headquartered in New York, New York, and primarily serves customers in New York and California.

Hone Health

Venture Round in 2024
Hone Health is a modern men's health platform that specializes in personalized care through data-driven insights and licensed physician consultations. The company provides a range of services, including access to medications such as testosterone, clomid, and anastrozole. Hone Health also offers a telemedicine kit designed to monitor hormone optimization, enabling users to track their hormonal changes effectively. Through its FDA-approved testing system, the platform facilitates consultations for anti-aging treatments, allowing consumers to receive tailored treatment plans at an affordable cost. This comprehensive approach aims to enhance men's health by integrating medical expertise with technology for effective hormone management.

Shimmer

Seed Round in 2024
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.

Seismic Therapeutic

Series B in 2023
Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.

Allara

Series A in 2023
Allara is a healthcare program focused on providing specialized virtual care for women dealing with complex chronic health conditions, particularly polycystic ovary syndrome. The platform connects patients with medical providers and registered dietitians, offering a comprehensive approach that includes diagnostic testing, prescriptions, and personalized video consultations. Allara emphasizes holistic care, integrating dietary and lifestyle changes alongside nutrition counseling to help women manage their health effectively. Through its virtual appointments, the program aims to simplify access to expert care, enabling patients to track and improve their overall medical wellbeing.

Atropos Health

Venture Round in 2023
Atropos Health is a technology company based in Palo Alto, California, founded in 2019. It specializes in developing a digital prognostogram platform, known as the Atropos Evidence Platform, which transforms health data into actionable real-world evidence. By integrating electronic medical record (EMR) data, the platform generates digital evidence tailored to individual patient outcomes. This enables healthcare institutions, life science companies, and researchers to utilize previously siloed EMR data effectively. The platform aims to close evidence gaps in healthcare, enhance clinical outcomes through data-driven care, and accelerate research initiatives. Atropos Health serves caregivers, healthcare organizations, and risk-bearing entities, contributing to advancements in evidence-based healthcare.

Carenostics

Seed Round in 2023
Carenostics is a health technology company focused on addressing the underdiagnosis, undertreatment, and health inequities associated with chronic diseases. The company employs artificial intelligence and machine learning to analyze patient data collected during routine care. Its detection models integrate seamlessly into providers' electronic health records (EHRs), allowing for the identification of chronic conditions that may have gone undiagnosed. By projecting the potential decline of patients with these conditions, Carenostics enables healthcare providers to prioritize care for individuals who need it most, ultimately aiming to improve health outcomes and reduce disparities in chronic disease management.

Superluminal Medicines

Seed Round in 2023
Superluminal Medicines is a generative biological and chemical company accelerating new possibilities in drug discovery and development. Its platform quickly creates candidate-ready compounds using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure. They leverage cutting-edge computational and machine-learning techniques to accelerate identifying and optimizing novel drug candidates. Their approach combines high-throughput experimental data with advanced algorithms to uncover therapeutic compounds faster and more efficiently than traditional methods.

Remedial Health

Series A in 2023
Remedial Health operates as a wholesale distributor of medicine, catering to the vast network of approximately one million pharmacies and hospitals across Africa. The company addresses the prevalent inefficiencies in the healthcare supply chain, where providers often depend on open-air markets to acquire pharmaceuticals, leading to risks of counterfeit products. By offering a pharmacy operations and procurement management platform, Remedial Health enhances business-to-business access to medications. This platform incorporates technology that simplifies the ordering process and facilitates direct access to retail medicines from manufacturers or distributors, thereby improving workflow management and ensuring a more reliable supply of genuine medications for healthcare providers.

ReflexAI

Seed Round in 2023
ReflexAI develops artificial intelligence tools aimed at enhancing the training and performance of frontline teams across various sectors, including crisis services, emergency response, social services, and healthcare. The company's offerings focus on scalable AI solutions that provide advanced roleplay simulations and intelligent quality assurance, which improve outcomes for human interactions. By automating scoring and reporting processes, ReflexAI's tools help to optimize training efficiency while ensuring consistency and visibility, particularly in veteran mental health services. This approach not only saves time and resources but also empowers agents to deliver better support in critical situations.

Heading Health

Series A in 2023
Heading Health is a technology-enabled mental health platform focused on enhancing access to affordable mental health care. The platform provides personalized treatment solutions that utilize evidence-based therapeutics and innovative technologies, including Spravato, transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine. By offering these services, Heading Health aims to enable patients to experience meaningful improvements in their mental well-being through effective and accessible treatment options.

Every Health

Pre Seed Round in 2023
Tech-enabled healthcare solution for the underserved LGBTQIA+ community.

Aether Bio

Venture Round in 2023
Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get the chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.

Wave Life

Seed Round in 2023
Wave Life is a new kind of mental health platform that makes emotional wellbeing an achievable part of everyday life. The app's mental health coach and toolkit empower users to live each day with intention. Mental health coaching helps to build self-awareness, discover values, and cope with stress.

Journey Clinical

Series A in 2023
Journey Clinical is a platform that provides services to member psychotherapy practices that are independently owned and operated, and in no way owns, directs, or controls the mental healthcare clinicians providing care.

Carbon Reform

Seed Round in 2022
Carbon Reform is a climate-tech startup that offers a modular carbon capture and pollution-control device to reduce CO2 levels in the atmosphere. Carbon Reform combines climate and indoor health technology to produce decentralized, permanent carbon capture, energy savings, and occupant-healthy indoor air. Carbon Reform implements a multi-phase approach to determine what's in the air, and how they can work with the existing infrastructure to make it better.

Yes Hearing

Series A in 2022
Yes Hearing is a company that sells hearing aid accessories to make it easier for seniors to get hearing aids. The company's platform provides users with access to healthcare and hearing technologies through home visit therapy and remote care. It also offers a variety of hearing aid devices for people with hearing impairments. Yes Hearing was established in 2020 by Sam Shear and Oliver Philips in New York.

Shimmer

Seed Round in 2022
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.

BigHat Biosciences

Series B in 2022
BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

Cartography Biosciences

Series A in 2022
Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company has created a platform-based cell therapy that utilizes single-cell analysis to identify innovative CAR-T targets. This approach allows for the design of cancer immunotherapies tailored to the safest and most effective targets. By combining molecular biology and computational methods, Cartography enables clients to advance their studies in the development of these targeted treatments, aiming to improve outcomes for cancer patients.

Kindly

Seed Round in 2022
Kindly Health is a diagnostics platform for sexual care and performance health. Kindly Health offers complete solutions for sperm health and sexual performance in men, as well as low libido, PCOS, irregular periods, and menstrual pain in women. Kindly Health makes it more accessible by combining at-home diagnostic tests (including semen tests and polycystic ovary syndrome tests), telehealth consultations, and supplements.

Choiz

Seed Round in 2022
Choiz operates a healthcare platform designed to provide personalized medical treatments directly to patients in their homes. The service encompasses a comprehensive, end-to-end healthcare experience, which includes diagnosis, medication delivery, and ongoing care. By connecting patients with health professionals and facilitating the timely delivery of necessary medications, Choiz aims to make specialized care and treatment more accessible to everyone. The platform is built with a patient-centric approach, ensuring that individual needs are met throughout the healthcare journey.

Swing Therapeutics

Series A in 2022
Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regain control of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives.

MindRight Health

Seed Round in 2022
MindRight Health, Inc., founded in 2019 and based in Newark, New Jersey, offers mental health coaching through text messaging to support communities in overcoming trauma. The company aims to enhance health equity by providing accessible and inclusive mental health care, particularly for communities of color and low-income families. MindRight partners with healthcare payers and providers to deliver culturally-responsive coaching, ensuring that members receive support seven days a week throughout the year. By matching users with specific coaches based on their profiles, MindRight creates a continuum of nonclinical support tailored to youth who may avoid traditional clinical services due to stigma and accessibility issues. Additionally, the company supplies partners with real-time data on mental health needs within the community, helping to anticipate and prevent potential mental health crises.

Torigen Pharmaceuticals

Venture Round in 2022
Torigen Pharmaceuticals is dedicated to advancing cancer care for companion animals through innovative treatment options. Founded in 2013 and based in Farmington, Connecticut, the company focuses on developing immunotherapy solutions, particularly an experimental autologous cancer vaccine. This vaccine aims to activate the immune system to target specific tumor-associated antigens present on cancer cells, allowing for more effective detection and treatment of tumors. By providing alternatives to traditional, invasive methods such as surgeries and chemotherapy, Torigen seeks to improve the quality of life for pets facing cancer. The company builds on years of scientific research and is committed to pushing the boundaries of veterinary oncology.

OYE

Pre Seed Round in 2022
OYE is a wellness app focused on enhancing emotional well-being through mind-body practices and community engagement. The platform offers daily emotional check-ins, personalized goal setting, and mindful notifications to help users transform their emotions into creative actions. Available in both Spanish and English, OYE provides guided reflections and expressive movement practices aimed at shifting moods and improving interpersonal relationships. By fostering a supportive environment, OYE enables members of the Latino community to enhance their mental health, experience personal growth, and build connections regardless of their location.

Curebase

Series B in 2022
Curebase is a company that develops software aimed at transforming the management of clinical trials. Founded in 2017 and based in San Francisco, California, its platform facilitates faster and more cost-effective trial execution by streamlining participant eligibility, enrollment, education, and consent processes. The software automates many manual steps and allows drug companies to efficiently distribute their trials to clinics. Additionally, it provides sponsors with access to real-time data, enabling them to monitor trial progress and manage information effectively. Curebase's services cater to various sectors, including medical devices, biotechnology, and digital health startups, enhancing the overall efficiency of clinical research.

Nelly

Seed Round in 2022
Nelly provides a tool for medical practices that simplifies patient onboarding and payments. It creates the basis for stress-free and clear work in your practice by drastically reducing the administrative effort for doctors, MFAs, ZFAs, and patients with Nelly. 90% of all healthcare professionals perceive bureaucracy and administrative burdens as the biggest problem in the workplace. The company's mission is to reduce the administrative effort in the healthcare sector by simplifying documentation and payment processes in order to make the practice visit more patient- and employee-friendly.

Diligent Robotics

Series B in 2022
Diligent Robotics Inc. is a company based in Austin, Texas, that develops and manufactures hospital service robots, specifically designed to assist clinical and nursing staff with logistical tasks. Its flagship product, Moxi, is a robotic assistant equipped with advanced mobile manipulation, social intelligence, and human-guided learning capabilities. Moxi works collaboratively with healthcare teams, allowing clinical staff to focus more on direct patient care, thereby enhancing patient satisfaction and improving the overall quality and safety of service. Founded in 2017, Diligent Robotics aims to integrate artificial intelligence technologies into everyday environments, supporting healthcare providers in dynamic and semi-structured settings.

Rejuveron Life Sciences

Angel Round in 2022
Rejuveron Life Sciences AG, founded in 2019 and based in Zug, Switzerland, is a biotechnology platform company focused on developing and investing in therapies and technologies aimed at enhancing healthy aging and extending lifespan. The company seeks to advance innovative solutions by investing in promising ideas and talented individuals within the field of life sciences.

Starling Medical

Seed Round in 2022
Starling Medical focuses on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, integrating seamlessly into everyday bathroom routines. The company is developing a healthcare device that employs mass spectroscopy-based sensors to continuously monitor changes in urine composition. This technology aims to enable early detection of chronic health issues, allowing both patients and healthcare providers to intervene promptly and potentially prevent serious complications or hospitalizations. By offering predictive insights, Starling Medical aspires to enhance health outcomes through proactive monitoring.

Wavely Diagnostics

Seed Round in 2022
Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Skippet

Seed Round in 2022
Skippet is a software developer that offers an AI-powered platform enabling users to create custom digital solutions without the need for coding. By simply describing their problems in plain English, users can leverage Skippet's advanced language models and system integration knowledge to generate or modify applications and workflows. This innovative approach allows individuals and organizations to effectively organize their work and adapt software to meet evolving needs. Additionally, Skippet's capabilities extend to health screening solutions that facilitate quick self-reporting for employees, helping organizations manage COVID-19 protocols and make informed decisions regarding workplace safety. Overall, Skippet empowers users to address their unique challenges through personalized technology solutions.

AmorSui

Seed Round in 2022
AmorSui is a modern protective apparel company that specializes in the design and innovation of medical gowns and lab jackets for healthcare professionals. Founded in 2020 by Beau Wangtrakuldee, PhD, the company emerged from a personal experience that highlighted the need for better protective gear. AmorSui's products are characterized by their antimicrobial and static-resistant properties, offering protection against bodily fluids while being reusable and recyclable. The company focuses on delivering high-quality, comfortable, and eco-friendly personal protective equipment that is entirely made and sourced in the USA. Additionally, AmorSui provides a platform for managing and procuring reusable kits, utilizing data analytics to monitor product life cycles, thereby helping hospitals and companies reduce costs and minimize waste while ensuring employee safety.

Sonic Incytes

Series A in 2021
Sonic Incytes is a medical device start-up company developing quantitative ultrasound for point-of-care diagnostic and procedure guidance. our mission to enable routine assessment and management of liver health, with diagnostic accuracy you can count on.

Limbix

Series A in 2021
Limbix is a prescription digital therapeutic company focused on developing mental health treatments specifically for adolescents. The company combines clinical expertise with technological innovation, leveraging a diverse team of clinicians, product designers, researchers, and engineers to create effective therapeutic solutions. Limbix's flagship product, SparkRx, is a digital therapeutic designed to assist licensed healthcare professionals in treating young patients dealing with depression, anxiety, and other mental health issues. By offering evidence-based interventions, Limbix aims to enhance the lives of teenagers facing mental health challenges.

OxiWear

Pre Seed Round in 2021
OxiWear develops innovative ear-wearable devices that provide continuous oxygen monitoring and emergency alerts to help detect and prevent silent hypoxia, particularly in individuals with pulmonary hypertension, those at high altitudes, or engaged in high-intensity activities, including during COVID-19. The company's patented pulse oximeter is designed for both clinical and consumer use, allowing patients to monitor their oxygen levels effectively. By offering real-time monitoring and alerts, OxiWear enhances patient safety and peace of mind, ensuring that individuals can obtain timely medical assistance when necessary.

Aether Bio

Seed Round in 2021
Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get the chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.

Zeit Medical

Seed Round in 2021
Zeit Medical provides therapy for neurological injuries by identifying signature patterns in EEG and enables physicians to diagnose and treat with precision. The company was founded in 20202019 by Urs Naber and Orestis Vardoulis.

BIOMILQ

Series A in 2021
BIOMILQ is a Durham, North Carolina-based startup founded in 2020 that specializes in producing nutritionally equivalent human breast milk using cultured human mammary cells. The company has developed a mammary biomanufacturing platform aimed at creating bioauthentic human milk ingredients that support better health outcomes for infants. By leveraging advanced technology, BIOMILQ provides an alternative for mothers and caregivers seeking a nutritious and sustainable feeding option, promoting essential aspects of infant development, including immune, gut, and neurological health. The company's innovative approach empowers families with a comprehensive solution for early-life nutrition.

Options MD

Pre Seed Round in 2021
Options MD is a telemedicine platform focused on delivering personalized care for individuals experiencing severe and treatment-resistant mental illnesses. The platform utilizes artificial intelligence to match patients with innovative depression care options provided by psychiatric experts. By streamlining the referral process to in-house specialists, Options MD enables patients to access appropriate medical care more efficiently, aiming to improve their treatment outcomes.

Sonavi Labs

Seed Round in 2021
Sonavi Labs, Inc. is a Baltimore-based company that specializes in the development of medical devices and artificial intelligence-based software aimed at respiratory monitoring and diagnostic support. Founded in 2017, the company focuses on creating innovative products that analyze body sounds to assist in the diagnosis of respiratory diseases. By leveraging advanced technology, Sonavi Labs enables healthcare providers to detect, monitor, and potentially predict respiratory conditions by identifying abnormalities in the sounds produced by the body. This approach enhances the capabilities of medical professionals and aims to improve the patient experience in managing respiratory health.

Kenshō Health

Seed Round in 2021
Kenshō is a health company that lives in LA, operates on the internet, and promotes a whole-person philosophy of care: mind, body, and spirit. The company, founded and led by proven entrepreneurs Krista Berlincourt and Danny Steiner, pairs scientific research with personalization technology to take the guesswork out holistic health, whether you're looking for an honest answer or a trusted provider. Berlincourt is known for nurturing and scaling some of the most loved emerging technology brands like Simple, Acorns, and Microsoft from the ground up. Steiner was a digital innovation change agent at NBC, Conde Nast, and Hulu before breaking into health and wellness with Brami, a venture-backed superfood company.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that focuses on delivering personalized support through an innovative platform. This platform integrates advanced artificial intelligence and natural language processing with established therapeutic techniques to create engaging mental health tools. At the core of its offering is Woebot, a relational agent designed to provide continuous, empathic, and personalized care. By leveraging these technologies, Woebot Health enables individuals and businesses to access effective mental health support conveniently and seamlessly, fitting into everyday life and promoting overall well-being.

Crescent Health

Pre Seed Round in 2021
Crescent Health is working to make sleep health accessible to all. It hastens the development of individual health, beginning with sleep. They are employed by meet sleep coach. Connecting a sleep monitor to an app get monthly customized sleep plans, track sleep health, and find the ideal schedule.

Ruth Health

Pre Seed Round in 2021
Ruth Health is a telehealth facility focused on women's and prenatal care, aiming to empower parents throughout their pregnancy journey and beyond. By utilizing evidence-based expertise, the company enhances access to childbirth services, making them more affordable and enjoyable. Ruth Health's platform offers medical consultations and information on postpartum care, addressing common women's health issues such as painful sex and unwanted urination. It also provides at-home ultrasound services and online consultations with healthcare professionals, enabling women to take control of their health and confidently navigate family planning and parenthood.

Protenus

Series D in 2021
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

Gilgamesh Pharmaceuticals

Series A in 2021
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York that specializes in developing novel psychotropic drugs aimed at treating mental illnesses. Established in 2019, the company focuses on creating innovative compounds that enhance the therapeutic benefits of classic psychedelics while improving safety, tolerability, duration, and efficacy. Gilgamesh addresses the growing global mental health crisis by providing treatments for various neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. Through a combination of medicinal chemistry and drug development expertise, the company aims to accelerate the availability of effective therapies, ultimately improving the quality of life for individuals suffering from central nervous system disorders.

CareRev

Series A in 2021
CareRev is a healthcare staffing marketplace that connects medical facilities directly with per diem healthcare professionals, eliminating the need for vendors or agencies. Its online platform allows hospitals and outpatient facilities to efficiently fill shifts by accessing a pool of flexible clinical talent. This model not only expedites the staffing process but also helps facilities reduce costs and maintain appropriate nurse-to-patient ratios, ultimately enhancing the quality of patient care. By facilitating direct communication between healthcare providers and staff, CareRev empowers professionals to choose their work schedules and locations, promoting greater flexibility in the healthcare workforce. The company has received funding from notable investors, including Y Combinator and several prominent business angels.

Alloy Therapeutics

Series C in 2021
Alloy Therapeutics is a biotechnology company founded in 2017 and headquartered in Waltham, Massachusetts. The firm specializes in democratizing access to drug discovery through its innovative platforms and services. Its flagship offering, Alloy-Gx, is a suite of immunocompetent transgenic mice designed for optimal in vivo human antibody discovery. This royalty-free platform allows researchers broad and non-exclusive access to essential drug discovery tools, streamlining the process of antibody project development. By providing these resources, Alloy Therapeutics aims to facilitate advancements in antibody research and ultimately enhance the drug discovery landscape.

Cleo

Series C in 2021
Cleo is a family support system that employers offer working parents, by helping families navigate their journey from fertility, to pregnancy, to parenting of newborns, infants, toddlers, and children to age 5. Employers choose Cleo as a strategic partner to power their culture transformation and see increased employee retention, more diverse and inclusive workplaces, and reduced health claims. Cleo supports parents globally in 50+ countries and works with forward-thinking companies like eBay, LinkedIn, Uber, and Straus Family Creamery and many others. Cleo is headquartered in San Francisco and is backed by Felicis Ventures, Forerunner Ventures, Greylock Partners, and NEA. Learn more at hicleo.com.

BrightInsight

Series C in 2021
BrightInsight operates a digital health platform tailored for biopharma and medtech companies, focusing on the development and optimization of regulated drugs, devices, and software. Founded in 2017 and headquartered in San Jose, California, the company offers a global regulated platform that utilizes Internet of Things (IoT) technology. This platform facilitates the capture, transmission, and analysis of data from connected medical devices, combination products, and digital therapeutics. By adhering to rigorous security, privacy, and regulatory standards, BrightInsight enables its clients to enhance patient adherence and engagement, streamline their processes, and accelerate time to market while reducing implementation costs. With an additional office in Hägglingen, Switzerland, BrightInsight is positioned to support customers in navigating the complexities of the digital health landscape.

Breathwrk

Seed Round in 2021
The Breathwrk app offers easy to follow and highly effective guided breathing exercises that alleviate anxiety, promote sleep, increase energy, improve mood, help with athletic performance, and more!

ELANZA Wellness

Pre Seed Round in 2021
ELANZA Wellness is a virtual chronic care platform designed specifically for individuals with endometriosis and other chronic reproductive health conditions. The platform aims to provide comprehensive support by offering access to medical specialists, evidence-based therapies, and personalized treatment plans that promote symptom relief. ELANZA Wellness focuses on a whole-person care approach, developed by multidisciplinary teams, to ensure that patients feel heard and understood throughout their healthcare journey. By enabling users to access therapeutic programs and make informed lifestyle changes, the platform empowers individuals to take control of their health and well-being, ultimately fostering a better quality of life.

Harmonize

Series A in 2021
Harmonize is a technology company that provides a remote care platform aimed at enhancing the management of high-risk patients, particularly those who may be unfamiliar with digital tools and have multiple health conditions. Founded in 2019 and based in San Mateo, California, Harmonize focuses on streamlining technology implementation and clinical triage processes. Its platform integrates both advanced technology and personalized support to facilitate effective patient engagement and care. By guiding healthcare staff through triage and intervention routing, Harmonize significantly reduces overhead costs and improves operational efficiency. The platform's capabilities include enhancing patient adherence rates, reducing the workload associated with information triage, and lowering overall healthcare utilization costs, ultimately leading to better patient outcomes.

ATAI Life Sciences

Series D in 2021
ATAI Life Sciences AG is a biotechnology company based in Munich, Germany, with additional offices in Berlin and London, established in 2018. The company focuses on developing therapies for mental health disorders, utilizing psychedelic compounds and other innovative methods to address conditions such as depression, anxiety, and substance use disorders. ATAI collaborates with various partners and research institutions to advance its clinical-stage drug development pipeline, which includes multiple product candidates like psilocybin therapy, ketamine-based treatments, and other compounds aimed at enhancing mental well-being. The company's commitment to research in psychedelics and neuroscience drives its efforts to ensure the efficacy and safety of its therapies. Recognized for its contributions to mental health treatment, ATAI has secured partnerships and funding to support its initiatives, gaining attention for its advancements in understanding and treating mental health disorders.

Kenshō Health

Venture Round in 2021
Kenshō is a health company that lives in LA, operates on the internet, and promotes a whole-person philosophy of care: mind, body, and spirit. The company, founded and led by proven entrepreneurs Krista Berlincourt and Danny Steiner, pairs scientific research with personalization technology to take the guesswork out holistic health, whether you're looking for an honest answer or a trusted provider. Berlincourt is known for nurturing and scaling some of the most loved emerging technology brands like Simple, Acorns, and Microsoft from the ground up. Steiner was a digital innovation change agent at NBC, Conde Nast, and Hulu before breaking into health and wellness with Brami, a venture-backed superfood company.

Plume Clinic

Series A in 2021
Plume is a health tech company for the transgender community. The company focuses on radically increasing access to care, medication, and products for the trans community, supporting a bold, authentic and healthy lifestyle. Its vision is to make gender-affirming care available to anyone until it transforms healthcare for every trans life.

FULLFILL

Seed Round in 2021
FULLFILL is a digital health platform focused on providing virtual health coaching aimed at treating and preventing chronic conditions. Founded in 2019 and headquartered in Los Angeles, the company partners with employers to enhance employee health and reduce medical expenses. FULLFILL's evidence-based programs have demonstrated significant effectiveness, achieving double the medical results of competing programs and tenfold employee sign-up rates. The platform offers a comprehensive range of resources, including daily videos, podcasts, articles, workouts, and meal plans, all accessible online with 24/7 support from trained Master Coaches. FULLFILL's approach not only addresses issues like obesity, diabetes, and mental health but also boosts participation in other health initiatives offered by employers, while its services qualify as a medical expense. The program has garnered high satisfaction ratings, positioning it as a valuable tool for employee retention amid increasing health challenges, especially in the wake of COVID-19.

Dock Health

Pre Seed Round in 2021
Dock Health is a HIPAA compliant task management and collaboration platform designed for healthcare. The company is focused on solving some of the most pressing issues in healthcare by making communication and collaboration easier through thoughtful design and simplicity. Dock is on a mission to solve the workflow challenges and inefficiencies for clinicians and their teams. Dock Health hopes to improve patient care by giving medical teams a reliable and secure system to ensure the work gets done. Founded in 2016, Dock Health is headquartered in Boston, Massachusetts.

norahealth.ai

Pre Seed Round in 2021
In the next decade, expect a revolutionary redesign of healthcare for instant guidance. Starting from joint & muscle care, Nora is the first AI knowledge assistant that delivers precise and medically sound guidance right when you need it. Leveraging a seamless fusion of conversational AI and proprietary computer vision models to automatize patient intake and physical examination, we unlock immediate guidance and care access for acute pain in less than 10 minutes.

Hey Jane

Venture Round in 2021
Hey Jane is a telehealth startup that connects patients to healthcare providers that offer online medical consultations. The company's innovative Complete Care model utilizes technology for unparalleled layers of support: medical, emotional, and social. Since 2021, Hey Jane has helped nearly 20,000 patients get the care they need. And this is only the beginning; soon, we will reimagine care for even more common but underserved treatments, with the ultimate goal of becoming the most trusted healthcare company out there—one that pushes the boundaries of access with convenient, inclusive, and patient-driven care.

Rejuveron Life Sciences

Series A in 2020
Rejuveron Life Sciences AG, founded in 2019 and based in Zug, Switzerland, is a biotechnology platform company focused on developing and investing in therapies and technologies aimed at enhancing healthy aging and extending lifespan. The company seeks to advance innovative solutions by investing in promising ideas and talented individuals within the field of life sciences.

Caliber

Seed Round in 2020
Caliber is focused on transforming fitness coaching to make it accessible for the majority of Americans who do not meet physical activity guidelines. The company addresses the challenge of increasing physical activity not through motivation alone, but by facilitating behavioral change through effective coaching. Caliber connects individuals with expert fitness coaches and provides a highly-rated app that allows users to work out at their convenience while integrating fitness and nutrition data for a personalized experience. Members typically see a significant improvement in body composition within three months and engage in more workouts than users of competing platforms. Caliber operates in the personal training market, which is valued at $20 billion, and is poised to capitalize on the rapidly growing digital fitness sector projected to reach $37 billion by 2026. The company's science-based approach to fitness and nutrition, combined with personalized coaching, aims to help a diverse range of individuals achieve their health and fitness goals effectively.

Cerebral

Series A in 2020
Cerebral Inc. is a mental health telemedicine company that provides an online membership platform for telehealth visits and care counseling services. Founded in 2019 and headquartered in Walnut, California, Cerebral offers comprehensive support for individuals experiencing anxiety, depression, and insomnia. The platform facilitates medication management, counseling, and therapy, ensuring access to regular visits and communication with care counselors. It employs clinically proven symptom-based ratings and tracking methods to enhance patient care. By prioritizing accessibility and affordability, Cerebral aims to democratize high-quality mental health care, allowing patients to receive timely and effective treatment while following evidence-based guidelines throughout their wellness journey.

Included Health

Seed Round in 2020
Included Health is a healthcare company that offers a blend of virtual care, navigation, and community-based services aimed at enhancing the overall healthcare experience. By integrating technology with personalized care, the company provides members with guidance and advocacy for a wide range of health needs, including urgent and primary care, behavioral health, and specialty services. Included Health focuses on ensuring that individuals receive the appropriate care at the right time, utilizing compassionate and data-driven approaches to improve clinical outcomes and member satisfaction. Through its innovative model, Included Health seeks to redefine healthcare accessibility and quality for all individuals.

SISU Aesthetic Clinic

Series A in 2020
SISU Aesthetic Clinic operates a network of doctor-led, patient-centric medical clinics focused on delivering non-invasive aesthetic treatments. The clinic specializes in a range of personalized beauty services, including anti-wrinkle injections, lip fillers, facials, excessive sweat care, silhouette soft restoration, dermal fillers, and profile treatments. By prioritizing an empathetic approach to care, SISU aims to enhance patients' skin health and overall well-being, enabling them to lead quality lives.

Vidya Health

Venture Round in 2020
Vidya Health is the medical technology company based in London

Phosphorus

Venture Round in 2020
Phosphorus, Inc. is a clinical genetic testing company that specializes in developing diagnostic kits to identify inherited risks for various diseases, including cancer, heart disease, and vision loss. The company's offerings include PhosphorusONE, a genetic testing kit, along with specialized tests such as HeartMap for hereditary heart conditions and LipidMap for hereditary high cholesterol. Phosphorus also provides panel-based genetic testing across multiple medical fields, including fertility, cardiology, oncology, and neurology, as well as a COVID-19 saliva testing kit. The company utilizes next-generation sequencing technology to ensure high-quality, actionable results and operates a CLIA and CAP certified laboratory, allowing it to conduct tests in all 50 states. Additionally, Phosphorus offers a software platform called Element for managing genetic test data and provides research services. The company, founded in 2016 and headquartered in New York, New York, sells its products online and partners with healthcare providers and hospitals to enhance the integration of genetics in medical care.

Euphoria.LGBT

Seed Round in 2020
Our mission is to restore agency and dignity to transgender individuals in their process of gender transition via technology solutions. We offer a suite of technologies, enabling a better transition: - Solace. Provides information and resources to guide transgender people through whatever process of gender transition they desire. Now available, for free, on iOS & Android . - Bliss. A revolutionary savings app for the transgender community. Your Bliss fund is so much more than just passive savings – every time you get a push notification, it’s helping you move closer to being yourself. - Windfall. Premium and optional services that compliment Solace. Includes subscription products and company merchandise. - Clarity. A sense-of-self tracker to help measure gender identity, gender expression, and attraction. Brought to life by an amazing group of individuals on Kickstarter. - Catharsis. Coming Soon. A dedicated mental and emotional health platform designed for the trans community, by the trans community.

Diligent Robotics

Series A in 2020
Diligent Robotics Inc. is a company based in Austin, Texas, that develops and manufactures hospital service robots, specifically designed to assist clinical and nursing staff with logistical tasks. Its flagship product, Moxi, is a robotic assistant equipped with advanced mobile manipulation, social intelligence, and human-guided learning capabilities. Moxi works collaboratively with healthcare teams, allowing clinical staff to focus more on direct patient care, thereby enhancing patient satisfaction and improving the overall quality and safety of service. Founded in 2017, Diligent Robotics aims to integrate artificial intelligence technologies into everyday environments, supporting healthcare providers in dynamic and semi-structured settings.

Leda Health

Pre Seed Round in 2020
At Leda Health, our mission is to transform existing systems of sexual assault prevention, care, and justice to better serve survivors and the communities in which they live. We are currently developing a more holistic care program and expanding our services. To learn more about Leda Health, visit: https://www.leda.co/ https://www.facebook.com/ledahealth/ https://twitter.com/ledahealthco https://www.instagram.com/ledahealth/ https://www.linkedin.com/company/ledahealth/

Sonavi Labs

Venture Round in 2020
Sonavi Labs, Inc. is a Baltimore-based company that specializes in the development of medical devices and artificial intelligence-based software aimed at respiratory monitoring and diagnostic support. Founded in 2017, the company focuses on creating innovative products that analyze body sounds to assist in the diagnosis of respiratory diseases. By leveraging advanced technology, Sonavi Labs enables healthcare providers to detect, monitor, and potentially predict respiratory conditions by identifying abnormalities in the sounds produced by the body. This approach enhances the capabilities of medical professionals and aims to improve the patient experience in managing respiratory health.

CitusHealth

Seed Round in 2019
Citus Health Inc. is a New York-based company that specializes in creating a digital platform for post-acute care providers, known as Call Bell. This platform facilitates secure and real-time collaboration among patients, family caregivers, healthcare professionals, and community service providers. Citus Health's offerings include HIPAA-compliant messaging, electronic signature capabilities, supply capture, scheduling, and patient education tools. By streamlining communication and workflow processes, the platform aims to improve the quality of care and enhance the patient experience, while also optimizing financial outcomes for care providers. Since its incorporation in 2016, Citus Health has focused on making home-based care more accessible and efficient for all stakeholders involved in patient care.

NKGen Biotech

Seed Round in 2019
NKGen Biotech, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing innovative cell therapies using Natural Killer (NK) cells. The company focuses on creating autologous, allogeneic, and CAR-NK cell therapeutics to target neurodegenerative and oncological diseases. Utilizing proprietary technologies for cell expansion and activation, NKGen Biotech can significantly enhance the cytotoxic capabilities of NK cells, enabling their effective use in treating abnormal or diseased cells. Their product candidates, particularly the SuperNKTM (SNK) cells, are developed through a unique manufacturing and cryopreservation process that has demonstrated increased activity in laboratory settings. This advancement in NK cell therapy positions NKGen Biotech at the forefront of innovative treatments aimed at harnessing the human innate immune response.

Eight Sleep

Series C in 2019
Eight Sleep, Inc. is a sleep technology company based in New York, founded in 2014. It specializes in the manufacturing and sale of smart mattresses that feature advanced temperature control, allowing users to cool or heat each side of the bed according to their preferences. The products are designed to enhance comfort and support optimal rest, health, and daily functioning by tracking heart rate and other health metrics. In addition to smart mattresses, Eight Sleep offers a range of accessories, including sleep trackers, pillows, organic sheets, foundations, waterproof protectors, blue wave glasses, and gravity blankets. The company primarily sells its products online and is recognized for its innovation in the sleep industry, having been named one of the Most Innovative Companies in Consumer Electronics by Fast Company in 2018.

Augmedix

Series B in 2019
Augmedix, Inc. is a healthcare technology company based in San Francisco, California, with additional offices in Menlo Park and Dhaka, Bangladesh. Founded in 2012, Augmedix specializes in remote medical documentation and live clinical support through its cloud-based platform. The application transforms natural clinician-patient conversations into organized medical notes in real time, allowing healthcare providers to focus more on patient care and reducing the administrative burden associated with electronic health record documentation. By partnering with hospitals and health systems, Augmedix enhances clinical efficiency and decision-making, ultimately improving operational and financial outcomes. The platform is designed for use by both large healthcare organizations and individual practitioners, charging service fees for access to its remote documentation and clinical support services.

RoundTrip

Series A in 2019
RoundTrip is disrupting the medical transportation industry by providing on-demand medical transportation for hospitals, healthcare organizations, transportation organizations, and health plans.They get the ins and outs of care coordination because they started as paramedics and EMTs before earning MBAs and executive positions at some of the largest healthcare and medical transportation companies in the world. RoundTrip schedules, dispatches, and monitors non-emergency transportation for organizations and their riders in ten states. A few of their major partners include Mount Sinai Health System, Cooper University Health System, MD Anderson Cancer Center at Cooper, Nemours Children’s Hospital, Crozer-Keystone Health System, and GRTC (the government paratransit program) of Richmond and Henrico Counties, VA. It offers easy-to-use online and mobile platforms that connect patients with non-emergency medical transportation (NEMT).

Ro

Series B in 2019
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

HUBBLE

Venture Round in 2018
See, Easy. We believe buying contact lenses and glasses should be simple. Full stop. That’s why our goal is to deliver the easiest, most hassle-free contact lens and glasses experience in the world. Here’s how we see it at Hubble Contacts. If you’re spending all your time arguing with customer service reps, endlessly searching for the right pair of glasses, or trying to remember to reorder your contacts before they run out (again), you’re not focused on all the things the world has to offer. Like that incredible sunset outside your window, the text convos on your phone that make you laugh (until you cry), or the gummy, toothless grin smiling at you from across her highchair. Hubble Contacts was created out of the desire to make contact lenses accessible and affordable to as many people as possible. Over the years, we have continued to evolve and adapt to the changing needs of our customers, and expand our product line along the way to also include high quality eyeglasses and sunglasses. With a passion for eye care and a dedication to customer service, our mission remains making a difference in the industry. So, let Hubble’s world-class team take care of you — and your contacts and glasses. And you? You keep your eyes on the prize.

Ossium Health

Venture Round in 2018
Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.

Banyan

Venture Round in 2018
Banyan is a digital marketing and patient engagement platform dedicated to enhancing the connection between healthcare professionals and patients. Founded in 2013 and based in Orem, Utah, Banyan offers a HIPAA-compliant media consent application that allows medical practices to share authorized patient photos on social media platforms such as Facebook, Instagram, and Twitter. The platform further supports healthcare providers by facilitating online reviews through a streamlined request tool and ensuring accurate practice information across over 70 web directories. Banyan also provides personalized websites to establish credibility for practices and offers coaching to help clients strengthen their brands, improve search engine optimization, and increase patient acquisition and retention. Operating as a subsidiary of NUVI LLC since 2019, Banyan focuses on helping healthcare clients foster a more humanized approach to patient care through effective online engagement.

Landsdowne

Series A in 2018
Landsdowne is a developer focused on innovative battery technology, specifically designed to address the health risks associated with button batteries. The company is commercializing a solution that deactivates batteries after accidental ingestion, aiming to provide a safe alternative for international businesses. Landsdowne's products not only target the growing health crisis related to button batteries but also include materials for injury prevention, ensuring that vulnerable individuals, such as those with fragile skin, are protected. By offering a turnkey, cost-effective solution, Landsdowne seeks to enhance safety and mitigate the risks posed by button batteries in various applications.

Sonavex

Series A in 2018
Sonavex, Inc. is a Baltimore-based company founded in 2013 that specializes in advanced imaging technology aimed at enhancing surgical outcomes. The company has developed a proprietary ultrasound-based platform that enables clinicians to detect anastomotic blood clots and assess critical intravascular flow metrics directly at the point of care. This technology not only facilitates the measurement of blood flow and vessel morphology but also includes bioresorbable and echogenic equipment to mark at-risk blood vessels for future assessments. By providing actionable data, Sonavex supports healthcare providers in monitoring and improving patient care, particularly in the context of post-operative complications.

Woebot Health

Series A in 2018
Woebot Health is a digital mental healthcare provider that focuses on delivering personalized support through an innovative platform. This platform integrates advanced artificial intelligence and natural language processing with established therapeutic techniques to create engaging mental health tools. At the core of its offering is Woebot, a relational agent designed to provide continuous, empathic, and personalized care. By leveraging these technologies, Woebot Health enables individuals and businesses to access effective mental health support conveniently and seamlessly, fitting into everyday life and promoting overall well-being.

Vixiar Medical

Venture Round in 2018
Vixiar Medical, Inc., founded in 2013 and located in Annapolis, Maryland, specializes in the development of non-invasive and cost-effective devices for monitoring cardiopulmonary diseases. The company focuses on conditions that impose significant clinical and economic challenges. Its flagship product, Indicor, is a handheld point-of-care device coupled with a digital platform, designed specifically for monitoring worsening heart failure. Through its innovative approach, Vixiar Medical aims to improve patient outcomes and reduce healthcare costs associated with cardiopulmonary conditions.

Landsdowne

Seed Round in 2018
Landsdowne is a developer focused on innovative battery technology, specifically designed to address the health risks associated with button batteries. The company is commercializing a solution that deactivates batteries after accidental ingestion, aiming to provide a safe alternative for international businesses. Landsdowne's products not only target the growing health crisis related to button batteries but also include materials for injury prevention, ensuring that vulnerable individuals, such as those with fragile skin, are protected. By offering a turnkey, cost-effective solution, Landsdowne seeks to enhance safety and mitigate the risks posed by button batteries in various applications.

Scene Health

Seed Round in 2015
Scene Health, formerly known as Emocha Health, addresses the longstanding issue of medication nonadherence by utilizing a comprehensive approach that combines technology, education, and personalized support. The company offers a mobile app that facilitates daily video check-ins, allowing patients to connect with healthcare professionals, including pharmacists and nurses, from anywhere at any time. This innovative platform enhances the traditional Directly Observed Therapy model by providing personalized video coaching and motivational content, thereby engaging patients and their families in their health management. Scene Health's solutions are designed to tackle the $500 billion medication nonadherence problem by identifying and addressing barriers related to social determinants of health. With over 120 clients in the healthcare sector, Scene Health aims to improve medication adherence for patients with chronic and infectious diseases, ultimately enhancing public health outcomes and reducing healthcare costs associated with nonadherence.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.